Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S L Cohn

Showing results (71-80 of 91) with videos related to

Pageof 10
Sort By:
Lancet (London, England)|February 9, 1991
Do children benefit from mass screening for neuroblastoma? Consensus Statement from the American Cancer Society Workshop on Neuroblastoma ScreeningS B Murphy, S L Cohn, A W Craft, et al.
Journal of the National Cancer Institute|March 5, 1997
Genetic staging of unresectable or metastatic neuroblastoma in infants: a Pediatric Oncology Group studyL C Bowman, R P Castleberry, A Cantor, et al.
Progress in Clinical and Biological Research|January 1, 1994
Preferential amplification of the paternal allele in neuroblastomas with N-myc amplificationJ M Cheng, J L Hiemstra, S S Schneider, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 14, 2000
Implications of EPHB6, EFNB2, and EFNB3 expressions in human neuroblastomaX X Tang, H Zhao, M E Robinson, et al.
Oncogene|December 1, 1990
Prolonged N-myc protein half-life in a neuroblastoma cell line lacking N-myc amplificationS L Cohn, H Salwen, M W Quasney, et al.
Neoplasia (New York, N.Y.)|June 23, 2001
Detection of MYCN gene amplification in neuroblastoma by fluorescence in situ hybridization: a pediatric oncology group studyP Mathew, M B Valentine, L C Bowman, et al.
Neoplasia (New York, N.Y.)|August 10, 2000
Lack of homozygously inactivated p73 in single-copy MYCN primary neuroblastomas and neuroblastoma cell linesX T Kong, V A Valentine, S T Rowe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 2005
Evidence for an age cutoff greater than 365 days for neuroblastoma risk group stratification in the Children's Oncology GroupW B London, R P Castleberry, K K Matthay, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|July 3, 2004
International Hermelin brain tumor symposium on matricellular proteins in normal and cancer cell-matrix interactionsT J Bos, S L Cohn, H K Kleinman, et al.
American Journal of Epidemiology|November 5, 1999
Hormone and fertility drug use and the risk of neuroblastoma: a report from the Children's Cancer Group and the Pediatric Oncology GroupA F Olshan, J Smith, M N Cook, et al.
Pageof 10

Showing results (71-80 of 91) with videos related to

Sort By:
Pageof 10
Lancet (London, England)|February 9, 1991
Do children benefit from mass screening for neuroblastoma? Consensus Statement from the American Cancer Society Workshop on Neuroblastoma ScreeningS B Murphy, S L Cohn, A W Craft, et al.
Journal of the National Cancer Institute|March 5, 1997
Genetic staging of unresectable or metastatic neuroblastoma in infants: a Pediatric Oncology Group studyL C Bowman, R P Castleberry, A Cantor, et al.
Progress in Clinical and Biological Research|January 1, 1994
Preferential amplification of the paternal allele in neuroblastomas with N-myc amplificationJ M Cheng, J L Hiemstra, S S Schneider, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 14, 2000
Implications of EPHB6, EFNB2, and EFNB3 expressions in human neuroblastomaX X Tang, H Zhao, M E Robinson, et al.
Oncogene|December 1, 1990
Prolonged N-myc protein half-life in a neuroblastoma cell line lacking N-myc amplificationS L Cohn, H Salwen, M W Quasney, et al.
Neoplasia (New York, N.Y.)|June 23, 2001
Detection of MYCN gene amplification in neuroblastoma by fluorescence in situ hybridization: a pediatric oncology group studyP Mathew, M B Valentine, L C Bowman, et al.
Neoplasia (New York, N.Y.)|August 10, 2000
Lack of homozygously inactivated p73 in single-copy MYCN primary neuroblastomas and neuroblastoma cell linesX T Kong, V A Valentine, S T Rowe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 2005
Evidence for an age cutoff greater than 365 days for neuroblastoma risk group stratification in the Children's Oncology GroupW B London, R P Castleberry, K K Matthay, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|July 3, 2004
International Hermelin brain tumor symposium on matricellular proteins in normal and cancer cell-matrix interactionsT J Bos, S L Cohn, H K Kleinman, et al.
American Journal of Epidemiology|November 5, 1999
Hormone and fertility drug use and the risk of neuroblastoma: a report from the Children's Cancer Group and the Pediatric Oncology GroupA F Olshan, J Smith, M N Cook, et al.
Pageof 10